Showing 1 - 10 of 613,248
international burden-sharing system. In the area of patent legislation that relates to pharmaceuticals, the federal government … expected to result in large price reductions, now slated to come into force in January 2022. But in designing policies and … community that shares in the financing of pharmaceutical R&D under the current global patent system. In this Commentary, we …
Persistent link: https://www.econbiz.de/10013289041
Persistent link: https://www.econbiz.de/10011405945
Persistent link: https://www.econbiz.de/10011869307
Constantly rising expenditures for pharmaceuticals require government intervention in firms' pricing decisions. To this … the introduction of a reference price leads to lower equilibrium prices and induces fiercer competition between firms …
Persistent link: https://www.econbiz.de/10011976973
Persistent link: https://www.econbiz.de/10011293117
Persistent link: https://www.econbiz.de/10011795264
In limiting the patent term to twenty years, Congress sought to use competition to make patented products available to … the public at low prices once inventors have reaped the fruits of the exclusivity provided by the patent grant. But … competition has in practice proven an unreliable method of achieving low prices for off-patent products. Patentholders reap supra …
Persistent link: https://www.econbiz.de/10014103805
Persistent link: https://www.econbiz.de/10001368360
Persistent link: https://www.econbiz.de/10013040759